Immuron (ASX:IMC) Other Current Receivables: A$1.54 Mil (As of Dec. 2025)


What is Immuron Other Current Receivables?

Immuron ASX:IMC +2.86% Other Current Receivables is A$1.54 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

Immuron's Other Current Receivables for the quarter that ended in Dec. 2025 was A$1.54 Mil.

Immuron's quarterly Other Current Receivables increased from Dec. 2024 (A$1.09 Mil) to Jun. 2025 (A$1.14 Mil) and increased from Jun. 2025 (A$1.14 Mil) to Dec. 2025 (A$1.54 Mil).

Immuron's annual Other Current Receivables increased from Jun. 2023 (A$0.40 Mil) to Jun. 2024 (A$0.80 Mil) and increased from Jun. 2024 (A$0.80 Mil) to Jun. 2025 (A$1.14 Mil).

Immuron Other Current Receivables Related Terms

Immuron Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Immuron's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Immuron Other Current Receivables Chart

Immuron Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.31 0.46 0.40 0.80 1.14

Immuron Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.80 1.09 1.14 1.54

Immuron Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of A$1.54 Mil mean?
Immuron (ASX:IMC) has a Other Current Receivables of A$1.54 Mil as of Dec. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Immuron and its competitors.
Is Immuron's Other Current Receivables too high?
Immuron's current Other Current Receivables is A$1.54 Mil.
How does Immuron's Other Current Receivables compare to VRTX and REGN?
Immuron's Other Current Receivables of A$1.54 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Immuron and its competitors. Immuron's current Other Current Receivables is A$1.54 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Immuron stock overvalued right now?
Based on GuruFocus' analysis, Immuron (ASX:IMC) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.23, compared to a current price of A$0.04 — trading 84.3% below its estimated fair value. The current Other Current Receivables is A$1.54 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Immuron (ASX:IMC), the current Other Current Receivables is A$1.54 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Immuron Business Description

Other Exchanges IMRN:USAANW:Germany
Address 25-37, Chapman Street, Unit 10, Blackburn, Melbourne, VIC, AUS, 3130
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.